LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 49 filers reported holding LUMOS PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,222 | 0.0% | 47,643 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $157,222 | -2.7% | 47,643 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $161,510 | -6.1% | 47,643 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $171,991 | -59.2% | 47,643 | 0.0% | 0.00% | -63.6% |
| Q3 2022 | $422,000 | +15.0% | 47,643 | 0.0% | 0.01% | +37.5% |
| Q2 2022 | $367,000 | -18.4% | 47,643 | 0.0% | 0.01% | -11.1% |
| Q1 2022 | $450,000 | +36.0% | 47,643 | 0.0% | 0.01% | +50.0% |
| Q4 2021 | $331,000 | -26.9% | 47,643 | 0.0% | 0.01% | -33.3% |
| Q3 2021 | $453,000 | -13.2% | 47,643 | -9.3% | 0.01% | 0.0% |
| Q2 2021 | $522,000 | -15.1% | 52,543 | 0.0% | 0.01% | -18.2% |
| Q1 2021 | $615,000 | -1.8% | 52,543 | +199.5% | 0.01% | -15.4% |
| Q4 2020 | $626,000 | +158.7% | 17,543 | 0.0% | 0.01% | +116.7% |
| Q3 2020 | $242,000 | +21.6% | 17,543 | +45.7% | 0.01% | +50.0% |
| Q2 2020 | $199,000 | +95.1% | 12,043 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $102,000 | – | 12,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 10,175 | $70,512,000 | 0.26% |
| Minerva Advisors LLC | 34,015 | $236,000 | 0.14% |
| Investors Financial Group, LLC | 30,600 | $212,000 | 0.10% |
| Lion Point Capital, LP | 51,205 | $354,000 | 0.10% |
| NEA Management Company, LLC | 376,916 | $2,612,000 | 0.05% |
| Wealth Advisors of Iowa, LLC | 11,699 | $81,000 | 0.04% |
| Paladin Advisory Group, LLC | 4,382 | $30,000 | 0.02% |
| Marquette Asset Management, LLC | 13,315 | $92,000 | 0.02% |
| Blackstone Inc. | 468,145 | $3,244,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $331,000 | 0.01% |